Fidelity International
OM icon

Fidelity International’s Outset Medical OM Stock Holding History

Fidelity International’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-23,842
Closed -$6.58M – 841
2023
Q1 		$6.58M Buy
23,842
+143
+0.6% +$52.5K 0.01% 533
2022
Q4 		$9.18M Sell
23,699
-128
-0.5% -$36.1K 0.01% 508
2022
Q3 		$5.69M Buy
23,827
+141
+0.6% +$37.8K 0.01% 566
2022
Q2 		$5.28M Sell
23,686
-33,681
-59% -$14.5M 0.01% 584
2022
Q1 		$39.1M Sell
57,367
-620
-1% -$373K 0.04% 335
2021
Q4 		$40.1M Buy
57,987
+2,337
+4% +$1.73M 0.04% 340
2021
Q3 		$41.3M Buy
55,650
+41,400
+291% +$28.2M 0.05% 326
2021
Q2 		$10.7M Buy
14,250
+11,379
+396% +$8.7M 0.01% 547
2021
Q1 		$2.34M Buy
2,871
+2,854
+16,788% +$2.2M ﹤0.01% 666
2020
Q4 		$14K Buy
+17
New +$13.1K ﹤0.01% 803

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity International's OM Position: Q2 2023 in Review

Fidelity International sold out of Outset Medical (OM) in Q2 2023, closing a stake of 23,842 shares — an estimated $6.58M sold.

Fidelity International first reported a position in OM in Q4 2020 and held it in 10 quarters. The position peaked at $41.3M in Q3 2021. 154 funds tracked by Wall St. Rank hold OM as of Q2 2023.

  • Fidelity International reported no remaining Outset Medical position as of Q2 2023 after selling out during the quarter.
  • Fidelity International sold 23,842 Outset Medical shares in Q2 2023, an estimated $6.58M.
  • Fidelity International first reported a position in Outset Medical in Q4 2020 and held it in 10 quarters.
  • Fidelity International's Outset Medical position peaked at $41.3M in Q3 2021.
  • 154 funds tracked by Wall St. Rank held Outset Medical as of Q2 2023.

Based on Fidelity International's 13F filing for Q2 2023, filed 11 Aug 2023.